Taysha Gene Therapies, Inc. - 10-Q Filing

Taysha Gene Therapies reports Q3 financial results featuring significant research and development activity and ongoing debt obligations related to Trinity Term Loans.

SEC EDGAR · November 12, 2026, 12:30 UTC

Tickers: $TSHA

Read the full article at SEC EDGAR

Part of the story Taysha Gene Therapies, Inc. - 10-Q Filing (2 articles)

More Regulatory news

INCOME OPPORTUNITY REALTY INVESTORS INC /TX/ - 10-Q Filing SEC EDGAR · November 12, 2026, 17:35 UTC
TRANSCONTINENTAL REALTY INVESTORS INC - 10-Q Filing SEC EDGAR · November 12, 2026, 17:33 UTC
AMERICAN REALTY INVESTORS INC - 10-Q Filing SEC EDGAR · November 12, 2026, 17:31 UTC
Home Federal Bancorp, Inc. of Louisiana - 10-Q Filing SEC EDGAR · November 12, 2026, 17:12 UTC
LiveRamp Holdings, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 16:52 UTC
Presurance Holdings, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 16:43 UTC
EXPEDITORS INTERNATIONAL OF WASHINGTON INC - 8-K Filing SEC EDGAR · November 12, 2026, 16:42 UTC
AUDIOEYE INC - 10-Q Filing SEC EDGAR · October 26, 2026, 21:11 UTC
ROCKWELL AUTOMATION, INC - 10-K Filing SEC EDGAR · November 12, 2026, 16:35 UTC
United KSK Corp - 10-Q Filing SEC EDGAR · November 12, 2026, 16:29 UTC